Churg-Strauss syndrome after zafirlukast in two patients not receiving systemic steroid treatment

Lancet

Volumn 353, Issue 9154, 1999, Pages 725-726

  Green, Richard L ^a   Vayonis, Andrew G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; FLUTICASONE; PREDNISONE; SALMETEROL; THEOPHYLLINE; ZAFIRLUKAST;

ADULT; AGED; ARTICLE; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; COUGHING; EOSINOPHILIA; FEMALE; FEVER; INTRANASAL DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VASCULITIS;

EID: 0033608427     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00565-6     Document Type: Article

References (4)

1. Wechsler ME, Garpestad E, Flier SR, et al. Pulmonary infiltrates, eosinophilia, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving Zafirlukast. JAMA 1998; 279: 455-57.
2. Josefson D. Asthma drug linked with Churg-Strauss syndrome. BMJ 1997; 315: 330.
3. Churg A, Churg J. Steroids and Churg-Strauss syndrome. Lancet 1998; 352: 32.
4. Masi AT, Hunder GG, Lie JT, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss Syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990; 33: 1094-100.